Zydus Lifesciences

Company also signs licensing deal for exclusive rights to immuno-oncology therapies Botensilimab and Balstilimab in India and Sri…

The tablets, used for treating IBS-D in adults, will be manufactured at the company’s SEZ II facility in Ahmedabad

The ‘Easiest Exam’ Campaign promotes awareness through a blend of storytelling, medical expertise, and digital engagement

President of India Droupadi Murmu confers Padma Bhushan on Pankaj Patel, Chairman of Zydus Lifesciences, for his work in advancing…

Zydus signs share purchase agreement to acquire majority stake in Amplitude Surgical, subject to regulatory approval and closing…

Approval allows Zydus to manufacture and market 1-gram Methenamine Hippurate tablets in the United States

Zydus has reduced the cost of Letermovir by 91 per cent of the innovator price. ANVIMO will be available in dosages of 240 mg and…

This combination of vaccines, if found successful, will safeguard children against two lethal enteric diseases of global…

VaxiFlu-4 developed as per WHO-recommended composition for influenza protection

Zydus to handle US market launch of Albumin Solubilized Docetaxel injection